Category: Finance
-

Precision Cancer Genomics Company Adds $23M in Early Funds
Biofidelity says its process simplifies detection of genetic indicators in tumors enabling more precise therapies for cancer patients.
-

Start-Up to Discover Proteins for Difficult Drug Targets
A new biotechnology company designing proteins in the lab for difficult drug targets in a range of diseases is raising $100 million in venture funds.
-

Digital Mental Therapy Company to Go Public in Merger
A creator of game therapies for cognitive impairments is becoming a publicly-traded company through a special purpose acquisition company or SPAC.
-

Science/Tech AI Developer Raises $100M in New Funds
A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round.
-

Group Devising Lower Cost Clinical Trials
A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost.
-

NIH Begins Large-Scale Precision Nutrition Study
National Institutes of Health awarded new funds for academic and industry labs to develop algorithms for predicting individual responses to food and nutrition.
-

Plant Science Products Company Raises $6.1M in Early Funds
A maker of products derived from plants for vaccines and control of crop disease is raising $6.1 million in its first venture funding round.
-

Infographic – Venture Funds More Than Double in 2021
Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020.
-

Infographic – Cybersecurity Venture Funds Zoom in 2021
Venture funding for cybersecurity companies jumped sharply in 2021 to a record $21.8 billion raised for the year, nearly 2.5 times the amount raised in 2020.
-

AI Pharma Company Raises $15M in Early Funds
A company using algorithms to develop new drugs designed to better succeed in clinical trials is raising $15 million in its first venture round.